Searchable abstracts of presentations at key conferences in endocrinology

ea0032p298 | Clinical case reports - Thyroid / Others | ECE2013

Hypercalciuria in a patient with central diabetes insipidus

Ginis Alexandros , Kostoglou-Athanassiou Ifigenia

Central diabetes insipidus is characterized by increased water excretion which is corrected by the administration of antidiuretic hormone. Hypercalciuria is known to be associated with osteoporosis. The aim was to describe the case of a patient with central diabetes insipidus, hypercalciuria, vitamin D deficiency and severe osteoporosis.The case of a patient, female aged 64 years, presenting with central diabetes insipidus, hypercalciuria, vitamin D defi...

ea0011p266 | Diabetes, metabolism and cardiovascular | ECE2006

The effect of Greek mediterranean diet on trace elements and blood coagulation factors in type 2 diabetic patients

Ginis A , Tzioras C , Panayotou N , Phenekos C

Background and aims: DM2 has been associated with altered levels of trace elements and a prothrombotic state. We investigated the effect of a 28-day Greek mediterranean diet (rich in fiber, mono- and polyunsaturated fatty acids and complex carbohydrates) on serum concentration of trace ele-ments and blood factors participating in coagulation and fibrinolysis in 58 patients with DM2.Materials and methods: Blood trace elements and blood coagulation fac-tor...

ea0070ep42 | Adrenal and Cardiovascular Endocrinology | ECE2020

Evaluation of pulmonary function and dyspnea index in Greek COPD patients with at least one metabolic comorbidity versus the population of the study without comorbidities – AEOLOS study

Tryfon Stavros , Maniakos Nikolaos , Ginis Alexandros , Markou Ioanna-Laoutselnta

Introduction: Metabolic disorder has been frequently observed in chronic obstructive pulmonary disease (COPD) patients. In particular, metabolic comorbidities exert a major impact on patients’ morbidity and mortality. Diabetes mellitus, dyslipidemia and osteoporosis are among the most commonly reported metabolic comorbidities in patients with chronic lung disease. COPD patients with comorbidities, such as metabolic disease, are generally more dyspnoeic and have worse hea...

ea0070ep128 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Asthma control and quality of life in greek patients with metabolic disorders. Results from BOREAS study

Laparidou Sotiria , Seferlis Vasilios , Bertoli Maria , Papanastasiou Polyanthi , Ginis Alexandros

Introduction: Asthma is often associated with various comorbidities, which may affect its clinical intensity and severity. The mechanisms of adult–onset asthma may include several metabolic and inflammatory components that are common to the other diseases such as obesity, metabolic syndrome, type 2 diabetes mellitus (T2DM), cardiovascular diseases and psychiatric diseases.Objectives: Assessment of asthma symptom control and QoL in a subgroup of ast...

ea0011p32 | Bone | ECE2006

Baseline characteristics of postmenopausal Greek women with osteoporosis who had inadequate clinical response to antiresorptive medications.

Ginis A , Charalampidou E , Thalassinos N , the Hellenic OSSO Study Group N

Aims: The Observational Study of Severe Osteoporosis (OSSO) is a 12-month, European, prospective study aiming to assess the changes in Health Related Quality of Life (HRQoL) of women with osteoporosis (OP) and an inadequate clinical response to antiresorptive (AR) medications.Methods: In Greece, 263 of 271 (97%) patients (pts) with severe OP met the inclusion criteria. The study population was assigned to1of 2 groups according to one or more of the follo...

ea0070ep65 | Bone and Calcium | ECE2020

Differential clinical expression of primary hyperparathyroidism due to a parathyroid adenoma or hyperplasia

Kostoglou-Athanassiou Ifigenia , Athanassiou Lambros , Ginis Alexandros , Fortis Athanasios , Kalogirou Thomais , Athanassiou Panagiotis

Introduction: Primary hyperparathyroidism is nowadays frequently diagnosed due to routine blood calcium measured in the general biochemical profile. Primary hyperparathyroidism may be due to a parathyroid adenoma or parathyroid hyperplasia. Parathyroid adenoma may occur in the area of the parathyroid glands or may be ectopic.Aim: The aim was to describe the differential clinical expression of primary hyperparathyroidism due to an adenoma or hyperplasia i...

ea0070ep89 | Bone and Calcium | ECE2020

Cortisol secreting adrenal adenoma. A clinically silent cause of osteoporosis

Kostoglou-Athanassiou Ifigenia , ATHANASSIOU Lambros , Ginis Alexandros , Manta Erasmia , Tsakiridis Pavlos , Giannakopoulos Andreas , Pastroudis Alexandros , Athanassiou Panagiotis

Adrenal adenomas are nowadays frequently diagnosed in the context of abdominal imaging. Osteoporosis may be a presenting manifestation of a cortisol producing adrenal adenoma. The aim was to present two cases of patients diagnosed and treated for osteoporosis who later in the course of the disease were diagnosed with a cortisol producing adrenal adenoma. Two patients, female aged 53 and 56 years, respectively, presented with osteoporosis. T score was −2.8 and &#...

ea0035p139 | Calcium and Vitamin D metabolism | ECE2014

Ghrelin may have a role in obesity pathogenesis in patients with vitamin D deficiency

Arslan Muyesser Sayki , Topaloglu Oya , Karakose Melia , Ucan Bekir , Tutal Esra , Karbek Basak , Unsal Ilknur Ozturk , Gungunes Askin , Demirci Taner , Caliskan Mustafa , Ginis Zeynep , Sahin Mustafa , Cakal Erman , Ozbek Mustafa , Delibasi Tuncay

Aim: Several studies suggest a link between vitamin D and obesity. Vitamin D may play a role in obesity. Ghrelin is an orexigenic peptide which induces obesity by central and peripheral mechanisms. Administration of ghrelin promotes food intake and decreased fat utilisation in rodents. Ghrelin levels are decreased in obese individuals.The aim of this study was to evaluate the relationship between vitamin D status and ghrelin levels.Methods: All subjects ...

ea0029p1444 | Pituitary Clinical | ICEECE2012

Evaluation of cardiovascular risk factors and metabolic profile in hyperprolactinemic subjects

Sayki Arslan M. , Sahin M. , Esra T. , Cakir Ozkaya E. , Bozkurt Colak N. , Karbek B. , Ozturk Unsal I. , Ucan B. , Gungunes A. , Cakal E. , Ozbek M. , Topaloglu O. , Demirci T. , Karakose M. , Caliskan M. , Ginis Z. , Delibasi T.

Objective: Hyperprolactinemia has been reported to be associated with abnormalities of glucose metabolism and cardiovascular inflammatory markers. However, the metabolic effects of high prolactin levels are not adequately clarified. The aims of this study were to evaluate the effects of hyperprolactinemia on endothelial function, insulin sensitivity and inflammatory markers in prolactinoma diagnosed subjects.Methods: In total, 58 hyperprolactinemic subje...

ea0029p1725 | Thyroid (non-cancer) | ICEECE2012

Serum nesfatin-1 levels in overt and subclinical hyperthyroidism

Gungunes A. , Ginis Z. , Demirci T. , Cakir E. , Karbek B. , Sayki Arslan M. , Ozturk Unsal I. , Tutal Akkaya E. , Ucan B. , Cakal E. , Gultuna Ozguclu S. , Ozbek M. , Sahin M. , Topaloglu O. , Delibasi T.

Objective: Nesfatin-1, was recently discovered in the brain which is derived from nucleobindin2 (NUCB2). Central and peripheral administration of nesfatin-1, inhibits food intake, dose-dependently. Hyperthyroid patients have increased appetite and food intake with a craving for carbohydrate-rich food, at the beginning of disease, but the physiological mechanisms underlying this behavior is not known exactly. In this study, we investigated whether nesfatin-1 is involved in the ...